Virus-like particle display of HER2 induces potent anti-cancer responses

Overexpression of human epidermal growth factor receptor-2 (HER2) occurs in 20–30% of invasive breast cancers. Monoclonal antibody therapy is effective in treating HER2-driven mammary carcinomas, but its utility is limited by high costs, side effects and development of resistance. Active vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales: Palladini, Arianna, Thrane, Susan, Janitzek, Christoph M., Pihl, Jessica, Clemmensen, Stine B., de Jongh, Willem Adriaan, Clausen, Thomas M., Nicoletti, Giordano, Landuzzi, Lorena, Penichet, Manuel L., Balboni, Tania, Ianzano, Marianna L., Giusti, Veronica, Theander, Thor G., Nielsen, Morten A., Salanti, Ali, Lollini, Pier-Luigi, Nanni, Patrizia, Sander, Adam F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790387/
https://www.ncbi.nlm.nih.gov/pubmed/29399414
http://dx.doi.org/10.1080/2162402X.2017.1408749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790387/
https://www.ncbi.nlm.nih.gov/pubmed/29399414
http://dx.doi.org/10.1080/2162402X.2017.1408749

Ejemplares similares